Survivors of Childhood Cancer More Likely to Experience Financial Burden
BY Brielle Urciuoli
A recent study looked at the financial effects that many survivors of childhood cancer face.
Boys Need the HPV Vaccine, Too
BY Prevent Cancer Foundation
Oropharyngeal cancer rates have been on the rise in men in the United States in recent years. The low HPV vaccine uptake rate, particularly among young men, is a major cause of the problem.
Using Playtime to Avoid Anesthesia in Children With Cancer
BY Allie Casey
When pediatric patients are given radiation treatment for cancer, they often get scared or nervous because they do not have an understanding of the process and the machines involved. To remedy this, anesthesia is used in many cases, though the long-term side effects are still unknown.
Study Finds a Decline in Late Effects After Childhood Treatment
BY Beth Fand Incollingo
There are fewer reported incidences of severe long-term side effects after childhood cancer treatment, according to a recent study. 
Despite Benefits, HPV Vaccination Rates Remain Too Low
BY Jason Harris
Despite impressive efficacy for the human papillomavirus (HPV) vaccine reducing the prevalence of high-risk oral HPV infections by 88 percent, many young adults still are not getting the vaccine – sparking concern in the health community.
The Kids at the Chemo Clinic: I Thought They Were Just Like Me
BY Ryan Hamner
A friend at the chemotherapy clinic told his story, but never said a word.
Siblings of Children with Cancer Gain Hope Through SuperSibs Program
BY Katie Kosko
Through their SuperSib program, Alex's Lemonade Stand is helping the siblings of children with cancer cope with their brother or sister's disease.
Flashy for a Cause: Raising Awareness for Childhood Cancers
BY Brielle Urciuoli
Chase After a Cure is running a Thunderclap campaign on Sept. 15 and is asking people to be flashy for a good cause: awareness and funds for childhood cancers.
Blincyto FDA Approved for Pediatric Acute Lymphoblastic Leukemia
BY Jason M. Broderick
The FDA has approved Blincyto (blinatumomab) for the treatment of pediatric and adolescent patients with Philadelphia chromosome-negative (Ph-) relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).
Special Feature
Share Your Art
Talk about this article with other patients, caregivers, and advocates in the Childhood CURE discussion group.
Search Cancer Drugs & Terms
//For side ad protocol